All guidelines recommend the importance of an effective vascular access for successful hemodialysis, emphasizing the recommendation of using autologous arteriovenous fistulas (AVFs) due to their favorable long-term patency and low complication rates. However, the decline in AVF usage is noted, attributed to demographic changes in the dialysis population, including an increase in very old patients with multiple comorbidities.
Methods:
We explore the results and performance of various vascular access types (AVF, arteriovenous graft, central vein catheter) in relation to late referral and patient demographics. We also discuss patient morbidity and mortality in relation to the chosen access type.
Conclusion:
The high risk of non-maturing autologous AVFs in elderly patients may justify the use of early stick grafts, and high-risk patients might benefit from permanent central vein catheters.
United States Renal Data System. USRDS 2024 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Disease, 2024.
2.
ERA-EDTA. Registry: ERA-EDTA registry 2022 annual report. Amsterdam: Academic Medical Center, Department of Medical Informatics, 2022.
3.
MuracaMHElaminMBSidawyAN, et al. Autogenous versus prosthetic vascular access for hemodialysis: a systematic review and meta-analysis. J Vasc Surg2008; 48: 34S–47S.
4.
Alma SeiJAlsawasMMainouM, et al. Outcomes of vascular access for hemodialysis: a systematic review and meta-analysis. J Vasc Surg2016; 64: 236–243.
5.
United States Renal Data System. URDS 2010 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2010.
6.
Canadian Organ Replacement Register Annual Report 2011. Treatment of end-stage organ failure in Canada, 2000 to 2009. Ottawa, ON: Canadian Institute for Health Information, 2011.
7.
PortFK.The end-stage renal disease program: trends over the past 18 years. Am J Kidney Dis1992; 20: 3–7.
8.
RavaniPBrunoriGMandolfoS, et al. Cardiovascular comorbidity and late referral impact arteriovenous fistula survival: a prospective multicenter study. J Am Soc Nephrol2004; 15(1): 204–209.
9.
EthierJMendhelssohnDCElderSJ, et al. Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transpl2008; 23(10): 3219–3226.
10.
Van LoonMvan derMarkBeukersN, et al. Implementation of a vascular access quality programme improves vascular access care. Nephrol Dial Transpl2007; 22(6): 1628–1632.
11.
HodTPatibandlaBKVinY, et al. Arteriovenous fistula placement in the elderly: when is the optimal time?J Am Soc Nephrol2015; 26(2): 448–456.
12.
HiremathSKnollGWeinsteinMC.Should the arteriovenous fistula be created before starting dialysis? A decision analytic approach. PLoS One2011; 6(12): e28453.
13.
Leblic RamírezIRiera Del MoralLSánchez VillanuevaR, et al. Effect of a multidisciplinary team in the management of vascular access for hemodialysis. Nefrologia (Engl Ed)2024; 44(3): 450–452.
14.
FerringMClaridgeMSmithSA, et al. Routine pre-operative vascular ultrasound improves patency and use of arteriovenous fistulas for hemodialysis: a randomized trial. Clin J Am Soc Nephrol2010; 5(12): 2236–2244.
15.
GeorgiadisGSGeorgakarakosEIAntoniouGA, et al. Correlation of pre-existing radial artery macrocalcifications with late patency of primary radio-cephalic fistulas in diabetic hemodialysis patients. J Vasc Surg2014; 60(2): 462–470.
16.
LazaridesMKGeorgiadisGSAntoniouGA, et al. A meta-analysis of dialysis access outcome in elderly patients. J Vasc Surg2007; 45(2): 420–426.
17.
Van HoekFScheltingaMRKouwenbergI, et al. Steal in hemodialysis patients depends on type of vascular access. Eur J Vasc Endovasc Surg2006; 32(6): 710–717.
18.
LokCEHuberTSLeeT, et al.; National Kidney Foundation. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis2020; 75(Suppl 2): S1–S164.
19.
FilaBMagasSPavicP, et al. The importance of success prediction in angioaccess surgery. Int Urol Nephrol2016; 48: 1469–1475.
20.
PolkinghorneKRMcDonaldSPAtkinsRC, et al. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol2004; 15(2): 477–486.
21.
DrewDALokCECohenJT, et al. Vascular access choice in incident hemodialysis patients: a decision analysis. J Am Soc Nephrol2015; 26(1): 183–191.
22.
ScarrittTParagoneCMO’GormanRB, et al. Traditional versus early-access grafts for hemodialysis access: a single-institution comparative study. Am Surg2014; 80(2): 155–158.
23.
LokCEAllonMMoistL, et al. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas [REDUCE FTM I]. J Am Soc Nephrol2006; 17(11): 3204–3212.
24.
AllonMLokCE.Dialysis fistula or graft: the role for randomized clinical trials. Clin J Am Soc Nephrol2010; 5(12): 2348–2354.
25.
BuurLEMadsenJKEidemakI, et al. Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? A systematic review. BMC Nephrol2021; 22: 307.
26.
VerberneWRvan den WittenboerIDVoorendCGN, et al. Health-related quality of life and symptoms of conservative care versus dialysis in patients with end-stage kidney disease: a systematic review. Nephrol Dial Transplant2021; 36: 1418–1433.
27.
DavisonSNTupalaBWasylynukBA, et al. Recommendations for the care of patients receiving conservative kidney management: focus on management of CKD and symptoms. Clin J Am Soc Nephrol2019; 14: 626–634.
28.
CarsonRCJuszczakMDavenportA, et al. Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease?Clin J Am Soc Nephrol2009; 4: 1611–1619.
29.
VoorendCGNvan OevelenMVerberneWR, et al. Survival of patients who opt for dialysis versus conservative care: a systematic review and meta-analysis. Nephrol Dial Transplant2022; 37: 1529–1544.
30.
HayashiRHuangENissensonAR.Vascular access for hemodialysis. Nat Rev Nephrol2006; 2: 504–513.
31.
RaimannJGBarthCUsvyatLA, et al. Dialysis access as an area of improvement in elderly incident hemodialysis patients: results from a cohort study from the International Monitoring Dialysis Outcomes Initiative. Am J Nephrol2017; 45: 486–496.
32.
DrouvenJWde BruinCvan RoonAM, et al. Vascular access creation in octogenarians: the effect of age on outcomes. J Vasc Surg2020; 72: 171–179.
33.
ArhuideseIJBeaulieuRJAridiHD, et al. Age-related outcomes of arteriovenous grafts for hemodialysis access. J Vasc Surg2020; 72: 643–650.
34.
YanTGameiroJGriloJ, et al. Hemodialysis vascular access in elderly patients: a comprehensive review. J Vasc Access2024; 25(1): 27–39.
35.
MureaMJamesKMRussellGB, et al. Risk of catheter-related bloodstream infection in elderly patients on hemodialysis. Clin J Am Soc Nephrol2014; 9: 764–770.
36.
MureaMGardeziAIGoldmanMP, et al. Study protocol of a randomized controlled trial of fistula vs. graft arteriovenous vascular access in older adults with end-stage kidney disease on hemodialysis: the AV access trial. BMC Nephrol2023; 24: 43.
37.
LokCE.Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol2007; 2: 1043–1053.
38.
LomonteCBasileCMitraS, et al. Should a fistula first policy be revisited in elderly haemodialysis patients?Nephrol Dial Transplant2019; 34: 1636–1643.
